GEN Exclusives

More »

GEN News Highlights

Back to Item »

Algeta Signs Deal to Combine Thorium Platform with Affibody’s Tumor-Targeting Molecules

Affibodies targeting Her2 and PDGFR-beta will be evaluated for its ability to deliver thorium-227 to cancer cells.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?